A survey by the Indonesian Survey Institute (LSI) reveals that a significant portion of the Indonesian public remains doubtful about the vaccine's ability to prevent the spread of the coronavirus. Nationally, 23.5% of the public express distrust in the benefits of vaccination.
The majority of the public who doubt the benefits of the Covid-19 vaccine are from Sulawesi. At least 32.9% of respondents in that region admitted to not believing that the vaccine can minimize the spread of Covid-19.
Public denial of the vaccine's effectiveness against the coronavirus is also prevalent in Sumatra, with 32.1% of respondents expressing such views. Furthermore, public distrust in the vaccine on the island of Java is spread across East Java (28.3%), Banten (21.1%), and Central Java (20.4%).
According to LSI Executive Director Djayadi Hanan, people complying with the emergency community activity restrictions (PPKM) tend to believe that the vaccine can prevent Covid-19 infection. In DKI Jakarta, for example, only 3.5% of respondents doubted the vaccine's effectiveness, the lowest percentage among all regions.
The LSI conducted a national telephone survey from June 20-25, 2021. This research involved 1,200 randomly selected respondents from all provinces in Indonesia. The survey's margin of error is ±2.88% with a 95% confidence level.